ArticleCell communication and signaling : CCS2026
Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation.
Guancong Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.